LOADING
Coronavirus, COVID-19, Entertainment, Gilead Sciences Inc, remdesivir, Science & Technology, US National Institutes of Health
Gilead’s remdesivir prevents lung damage in COVID-19 study on monkeys
June 10, 2020
[ad_1] Gilead Sciences Inc’s antiviral drug remdesivir prevented lung illness in macaque monkeys contaminated with the brand new coronavirus, based on a research printed within the journal Nature on Tuesday. The findings have been first ...
chat_bubble0 Comment
visibility250 Views
COVID-19, COVID-19 patients, Entertainment, Gilead Sciences Inc, highly contagious respiratory illness, novel coronavirus, remdesivir, Science & Technology
Report says COVID-19 patients respond to Gilead’s remdesivir, shares surge
April 17, 2020
[ad_1] Gilead Sciences Inc’s shares surged 16% in after hours buying and selling on Thursday following a media report detailing encouraging partial knowledge from trials of the US firm’s experimental drug remdesivir in extreme COVID-19 ...
chat_bubble0 Comment
visibility303 Views
Potential coronavirus treatment granted rare disease status
April 12, 2020
[ad_1] WASHINGTON: The pharmaceutical big that makes a promising coronavirus drug has registered it as a uncommon illness remedy with US regulators, a standing that may doubtlessly be price tens of millions in tax breaks ...
chat_bubble0 Comment
visibility253 Views
Popular Posts
